Abstract
Psychosocial interventions are an important adjunct to pharmacotherapies in the maintenance treatment of people with schizophrenia. In the pharmacological maintenance trials, when patients are switched to placebo after responding to acute phase treatment, up to 60% relapse within a year; on maintenance antipsychotics, this proportion is 24%, without important differences among the drugs.1,2 In other words, one in four patients with schizophrenia might still relapse under well-supervised maintenance pharmacotherapy within a year.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
